Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
Showing 4,201–4,260 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
…ed. Pharmacological activity was observed in the first patient (esophageal cancer, treated at 60-120-300ug), which exhibited a non-confirmed part…
…ted clinical activity was observed in patients with KRAS mutant NSCLC and in other solid tumors.Conclusions TNG260 in combination wit…
…ical response. ALC: absolute lymphocyte count (cells/uL). SCLC: small cell lung cancer. C1D1: Treatment Cycle 1 day 1 (1 cycle is 4 weeks)Abstract 565…
…41 per cohort) with recurrent or metastatic non-small cell lung cancer (NSCLC), melanoma, endometrial cancers, or head and neck squamo…
…dy.Results Twelve patients with advanced solid tumors—including colorectal cancer, cholangiocarcinoma, non-small cell lung cancer, ovarian cancer…
…n with immunotherapy.References Setty BA, Gikandi A, DuBois SG. Ewing sarcoma drug therapy: current standard of care and emerging agents. Pae…
…ncer brain metastasis.Methods Mice bearing intracranial tumors (GL261, U87, or E0771) underwent neuronavigation- or MRI-guided FUS BB…
…Background Diffuse midline glioma (DMG) is a fatal tumor characterized by H3K27M mutation that is…
…ent of immunosuppressive CD14 CTX was observed in patients with HCC and CPB but not CPA liver disease, indicating a potential mecha…
… only CAR T-cell therapy for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) [Internet]. Bristol M…
…disease (COPD) and pneumonia diagnoses from five years prior to lung cancer diagnosis onward, and advanced or metastatic cancer stage.Resul…
…try.Results Leuprolide leads to plaque formation in mice having Myc-CAP prostate tumors. Notably, plaque size and severity score were higher in leuprol…